Mozambique’s National Health Institute (INS) will carry out research to investigate the effectiveness of mixing two approved Covid-19 vaccines. On Monday, a statement from the International Vaccine Institute (IVI) announced that the INS-led Phase II trial will look at the safety and immunogenicity of a two-dose regimen using one dose of Sinopharm’s VeroCell Covid-19 vaccine … Continue reading Mix and match Covid-19 vaccine study to take place in Mozambique